Ginkgo Bioworks Holdings Current Ratio 2020-2023 | DNA
Ginkgo Bioworks Holdings current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Ginkgo Bioworks Holdings Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-03-31 |
$1.33B |
$0.19B |
6.92 |
| 2022-12-31 |
$1.45B |
$0.17B |
8.38 |
| 2022-09-30 |
$1.46B |
$0.13B |
11.71 |
| 2022-06-30 |
$1.60B |
$0.14B |
11.84 |
| 2022-03-31 |
$1.71B |
$0.16B |
10.71 |
| 2021-12-31 |
$1.72B |
$0.14B |
12.79 |
| 2021-09-30 |
$1.81B |
$0.09B |
20.05 |
| 2021-06-30 |
$0.00B |
$0.01B |
0.21 |
| 2021-03-31 |
$0.00B |
$0.00B |
2.10 |
| 2020-12-31 |
$0.00B |
|
0.00 |
| 2020-09-30 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.504B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
